CN Patent

CN104610265A — 一种化合物及其制备方法

Assigned to WUHU YANGYAN PHARMACEUTICAL Co Ltd · Expires 2015-05-13 · 11y expired

What this patent protects

本发明涉及医药技术领域，尤其涉及一种化合物及其制备方法。该化合物具有式(I)所示结构，药理实验表明该类化合物具有良好的抗肿瘤活性。此外，本发明还提供了制备该类化合物的方法，该方法具有反应步骤少、反应条件温和、收率高的优点。

USPTO Abstract

本发明涉及医药技术领域，尤其涉及一种化合物及其制备方法。该化合物具有式(I)所示结构，药理实验表明该类化合物具有良好的抗肿瘤活性。此外，本发明还提供了制备该类化合物的方法，该方法具有反应步骤少、反应条件温和、收率高的优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN104610265A
Jurisdiction
CN
Classification
—
Expires
2015-05-13
Drug substance claim
No
Drug product claim
No
Assignee
WUHU YANGYAN PHARMACEUTICAL Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.